LIXEA LIMITED

Their core work

LIXEA is a London-based technology SME that developed BioFlex, a proprietary process to dissolve waste wood and recover its constituent bio-based raw materials — cellulose, lignin, and hemicellulose — from timber waste streams. Their work sits at the intersection of green chemistry and circular economy: turning low-value or discarded wood into feedstocks for other industries. Within the H2020 programme, they moved from a Phase 1 feasibility study (SME-1, 2018) to a Phase 2 full development project (SME-2, 2020), reflecting a clear path from laboratory concept to commercial scale-up. Their entire known EU-funded portfolio is built around a single, deeply developed proprietary technology.

What they specialise in

How they've shifted over time

Both H2020 projects cover the same BioFlex technology, so there is no thematic shift in research direction — the focus has been consistent throughout. What did evolve is the technology readiness level: Phase 1 (2018–2019) established proof-of-concept and commercial feasibility, while Phase 2 (2020–2022) moved into full development and scale-up. The unusual shift from coordinator in Phase 1 to third-party role in Phase 2, with no recorded EC funding in the later project, may indicate a corporate restructuring or a changed legal entity during scale-up.

LIXEA is moving from R&D validation toward commercial deployment of a single proprietary technology, making them a potential licensing or supply-chain partner rather than a broad research collaborator.

How they like to work

LIXEA led the Phase 1 feasibility project as coordinator, then appeared as a third party in Phase 2 — an unusual pattern that likely reflects a corporate reorganization rather than a change in collaborative behavior. With only 2 unique partners across both projects and activity in 2 countries, this is a very small, tightly focused network. They are not a broad consortium builder; they bring one specific technology to the table and engage deeply around it.

LIXEA's recorded H2020 network is minimal — 2 unique consortium partners across 2 countries. Their collaboration footprint is among the smallest possible within the programme, reflecting a single-technology focus rather than broad partnership activity.

What sets them apart

LIXEA's differentiator is owning a specific, patentable process — the BioFlex wood dissolution technology — rather than offering broad R&D services. This makes them relevant to any consortium or company that needs to convert wood waste into bio-based feedstocks, whether in pulp and paper, construction, packaging, or specialty chemicals. A consortium builder would choose them not for research breadth but for access to a defined piece of IP and the team that developed it.

Highlights from their portfolio

• BioFlex
  The SME Phase 1 project where LIXEA acted as coordinator and secured EUR 50,000 to establish commercial feasibility of their wood dissolution process — the founding validation of their core technology.
• Bioflex
  The follow-on SME Phase 2 project (2020–2022), representing a successful step-up from feasibility to full development — one of the harder transitions in the SME Instrument pipeline.